EUROIMMUN is further expanding
As the board of directors and the supervisory board explained to the 250 present stockholders at the annual general meeting in July, 2013 was yet again a successful year for EUROIMMUN. The total turnover of the corporate EUROIMMUN group amounted to 148.3 million Euro, an increase of more than 20 million Euro compared to the […]